Since its establishment in 1996, Veritas IRB has reviewed studies of varying types and across almost all therapeutic areas. Our board membership is comprised of national experts and, if necessary, we have access to a select group of experienced and knowledgeable professionals.

Veritas IRB has also reviewed research conducted in a variety of settings including private clinics and research facilities, hospitals, academic institutions, governmental agencies, and within the workplace or the community.

Veritas IRB has developed specialized review panels for studies involving HIV, Phase I (First-in-human), bioequivalence, and population genomics which not only ensure specific scientific expertise but also community representation that takes into account the distinct aspects of the solicited research population in these studies.